en POLSKI
eISSN: 2300-8660
ISSN: 0031-3939
Pediatria Polska - Polish Journal of Paediatrics
Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

3/2022
vol. 97
 
Share:
Send email
Share:
abstract:
Case report

Mycophenolate mofetil-related colitis in a paediatric patient after kidney transplant

Natalia Oleksik
1, 2
,
Monika Głowinkowska
1, 2
,
Maria Szczepańska
2
,
Katarzyna Bąk-Drabik
2
,
Wioletta Jarmużek
3

  1. Students’ Association, Medical University of Silesia, Katowice, Poland
  2. Department of Paediatrics, Faculty of Medical Sciences in Zabrze, Students’ Association, Medical University of Silesia, Katowice, Poland
  3. Department of Nephrology, Kidney Transplantation and Hypertension, the Children’s Memorial Health Institute, Warsaw, Poland
Pediatr Pol 2022; 97 (3): 260-263
DOI: https://doi.org/10.5114/polp.2022.120122
Online publish date: 2022/10/18
View full text Get citation
 
PlumX metrics:
Mycophenolate mofetil (MMF) is an immunosuppressive agent, the gastrointestinal side effects of which include abdominal pain, diarrhoea, and vomiting. MMF may also cause symptomatic colitis, although it is a rare condition. We present herein the case of a boy with chronic kidney disease, lasting since the neonatal period, and caused by WT1 gene mutation. The patient developed colitis during an immunosuppressive therapy applied after a kidney transplant. Histopathology of intestinal biopsy specimens revealed features of MMF-related colitis. A modification of the immunosuppressive treatment and the implementation of a nutritional programme to the patient resulted in the disappearance of clinical signs and helped in a gradual body weight gain.
keywords:

children, mycophenolate mofetil, kidney transplant, colitis